Organon & Co. (OGN) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organon & Co..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.914 Thank you, Operator, and good morning, everyone. 00:00:01.914 -- 00:00:05.461 Thank you for joining Organon's first quarter earnings call. 00:00:05.461 -- 00:00:10.450 With me today are Kevin Ali, Organon's Chief Executive Officer, and Matt Walsh, our Chief 00:00:10.450 -- 00:00:15.459 Financial Officer. Juan Camilo Arjona-Ferreira, Organon's Head of R&D, will 00:00:15.459 -- 00:00:18.845 also be joining for the Q&A portion of this call. 00:00:18.845 -- 00:00:23.073 Today, we will be referencing a presentation that will be visible during this call for 00:00:23.073 -- 00:00:27.381 those of you on our webcast. This presentation will also be available following this 00:00:27.381 -- 00:00:34.326 call on the events and presentation section of our investor relations website, www.organon.com. 00:00:35.189 -- 00:00:38.993 Before we begin, I would like to caution listeners that certain information discussed 00:00:38.993 -- 00:00:43.398 by management during this conference call will include forward-looking statements. 00:00:43.398 -- 00:00:47.643 Actual results could differ materially from those stated or implied by forward-looking 00:00:47.643 -- 00:00:52.415 statements due to risks and uncertainties associated with the company's business, which 00:00:52.415 -- 00:00:56.779 are discussed in the company's filings with the Securities and Exchange Commission, including 00:00:56.779 -- 00:01:02.064 our 10-K and subsequent periodic filings. In addition, we will discuss certain 00:01:02.064 -- 00:01:06.889 non-GAAP financial measures on this call, which should be considered a supplement to 00:01:06.889 -- 00:01:11.653 and not a substitute for financial measures prepared in accordance with GAAP. 00:01:11.653 -- 00:01:15.657 A reconciliation of the...